Feb 22, 2023 / 09:30PM GMT
Operator
Good evening. My name is Rob, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Ligand Pharmaceuticals Fourth Quarter 2022 Earnings Webcast. (Operator Instructions) Thank you.
Simon Latimer, Head of Investor Relations. You may begin your conference.
Simon Latimer - Ligand Pharmaceuticals Incorporated - Head of IR
Thanks, Rob. Welcome to Ligand's Fourth Quarter of 2022 Financial Results and Business Update Conference Call. Speaking today for Ligand will be Todd Davis, CEO; Octavio Espinoza, CFO; and Matt Korenberg, President and COO. We will use non-GAAP financial measures, and some of our statements will be forward looking, including those related to our financial conditions, results of operations, financial guidance and the impact of the COVID-19 pandemic.
Additional information concerning risk factors and other matters concerning Ligand can be found in our earnings press release and our periodic filings with the SEC. We undertake no obligation to revise or update any statements to reflect events
Q4 2022 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers